§2847-N. Coverage for colorectal cancer screening
1.
Colorectal cancer screening.
For the purposes of this section, "colorectal cancer screening" means all colorectal cancer examinations and laboratory tests recommended by a health care provider in accordance with the most recently published colorectal cancer screening guidelines of a national cancer society.
[PL 2019, c. 86, §4 (AMD); PL 2019, c. 86, §10 (AFF).]
2.
Required coverage.
All group health insurance policies, contracts and certificates must provide coverage for colorectal cancer screening for asymptomatic individuals who are:
A.
At average risk for colorectal cancer according to the most recently published colorectal cancer screening guidelines of a national cancer society; or
[PL 2019, c. 86, §5 (AMD); PL 2019, c. 86, §10 (AFF).]
B.
At high risk for colorectal cancer.
[PL 2019, c. 86, §6 (AMD); PL 2019, c. 86, §10 (AFF).]
[PL 2019, c. 86, §§5, 6 (AMD); PL 2019, c. 86, §10 (AFF).]
3.
Billing.
If a colonoscopy is recommended by a health care provider as the colorectal cancer screening test in accordance with this section and a lesion is discovered and removed during that colonoscopy, the health care provider must bill the insurance company for a screening colonoscopy as the primary procedure.
[PL 2007, c. 516, §3 (NEW); PL 2007, c. 516, §5 (AFF).]
Revisor's Note:
§2847-N. Coverage for medically necessary infant formula (As enacted by PL 2007, c. 595, §3 is REALLOCATED TO TITLE 24-A, SECTION 2847-P)
SECTION HISTORY
PL 2007, c. 516, §3 (NEW). PL 2007, c. 516, §5 (AFF). PL 2019, c. 86, §§4-6 (AMD). PL 2019, c. 86, §10 (AFF).